title: [Influence of Qingdai compound on expression of bcr/abl and JWA in K562 cells].
abstract: To study the effects of Qingdai compound on proliferation and apoptosis of K562 cells, as well as the expression of bcr/abl and JWA mRNA, K562 cells were treated in culture with different concentrations of Qingdai compound (2.5, 5, 7.5, 10 and 20 mg/ml) and harvested at 24 hours. Then morphological changes were observed by light microscopy (LM); expressions of bcr/abl and JWA were detected with semi-quantitative RT-PCR. The results showed that morphological changes were observed as the increment of the Qingdai compound concentration. Inhibition effects on proliferation and apoptosis in K562 cells were seen. A concentration-dependent decreases were found in bcr-abl and JWA mRNA expression of K562 cells. Qingdai compound partially inhibited proliferation and induced apoptosis of K562 cells. Expressions of both bcr/abl and JWA, which took part in cell proliferation and apoptosis, were down-regulated in a dose dependent manner. In conclusion, Qingdai compound can partially inhibit the expressions of bcr/abl and JWA genes in K562 cells, and the clinical effect of Qingdai compound on CML may be associated with apoptosis of leukemic cells.
authors.affiliation: Department of Hematology, The Jiangsu TCM Hospital, Nanjing TCM University, Nanjing 210029, China.
authors.forename: Hai-Ping
authors.initials: HP
authors.lastname: Dai
authors.forename: Qun
authors.initials: Q
authors.lastname: Shen
authors.forename: Jian-Wei
authors.initials: JW
authors.lastname: Zhou
authors.forename: Wei-Yan
authors.initials: WY
authors.lastname: Tang
authors.forename: Guang-Rong
authors.initials: GR
authors.lastname: Zhu
authors.forename: Wen
authors.initials: W
authors.lastname: Xia
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006360:Heat-Shock Proteins / Q000235:genetics*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D020014:K562 Cells; D026901:Membrane Transport Proteins; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: C484566:ARL6IP5 protein, human; D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal; D006360:Heat-Shock Proteins; D047908:Intracellular Signaling Peptides and Proteins; D026901:Membrane Transport Proteins; D012333:RNA, Messenger; D016044:Fusion Proteins, bcr-abl; C530990:Qingdai compound